Total Payments
$12,422
2024 Payments
$367.04
Companies
52
Transactions
758
Medicare Patients
3,796
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$11,716 (94.3%)
Other$700.00 (5.6%)
Education$6.08 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,716 | 755 | 94.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $700.00 | 2 | 5.6% |
| Education | $6.08 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,363 | 101 | $0 (2024) |
| Allergan, Inc. | $1,270 | 49 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $939.19 | 50 | $0 (2024) |
| Amgen Inc. | $891.52 | 43 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $700.45 | 44 | $0 (2023) |
| Lundbeck LLC | $660.21 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $650.21 | 35 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $417.29 | 32 | $0 (2023) |
| Daiichi Sankyo Inc. | $365.41 | 37 | $0 (2019) |
| PFIZER INC. | $332.64 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $367.04 | 19 | ABBVIE INC. ($145.81) |
| 2023 | $1,313 | 79 | ABBVIE INC. ($467.88) |
| 2022 | $1,617 | 104 | ABBVIE INC. ($466.55) |
| 2021 | $1,776 | 107 | AbbVie Inc. ($282.68) |
| 2020 | $2,338 | 114 | Allergan, Inc. ($966.23) |
| 2019 | $1,885 | 117 | Amgen Inc. ($281.45) |
| 2018 | $1,632 | 114 | Amgen Inc. ($298.78) |
| 2017 | $1,494 | 104 | Pernix Therapeutics Holdings, Inc. ($211.28) |
All Payment Transactions
758 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/06/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Neuromodulation | ||||||
| 04/19/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.68 | General |
| Category: NEUROLOGY | ||||||
| 04/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: PAIN | ||||||
| 03/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: PAIN | ||||||
| 03/21/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.26 | General |
| Category: Opioid Analgesic | ||||||
| 03/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: PAIN | ||||||
| 02/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.68 | General |
| Category: Opioid Analgesic | ||||||
| 01/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: NEUROSCIENCE | ||||||
| 01/15/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $31.11 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/10/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.45 | General |
| Category: Opioid Analgesic | ||||||
| 01/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: PAIN | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Gastroenterology | ||||||
| 12/13/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: PAIN | ||||||
| 12/11/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: INSOMNIA | ||||||
| 12/07/2023 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.43 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 933 | 14,281 | $1.2M | $256,041 |
| 2022 | 14 | 952 | 16,135 | $1.3M | $281,164 |
| 2021 | 13 | 955 | 12,778 | $1.1M | $268,235 |
| 2020 | 13 | 956 | 12,046 | $1.1M | $223,627 |
Total Patients
3,796
Total Services
55,240
Medicare Billing
$1.0M
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 418 | 1,663 | $659,650 | $142,343 | 21.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 19 | 11,200 | $280,000 | $54,891 | 19.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 124 | 173 | $86,450 | $22,032 | 25.5% |
| 97124 | Therapy procedure using massage, each 15 minutes | Office | 2023 | 28 | 477 | $19,200 | $8,431 | 43.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 46 | 46 | $25,300 | $6,959 | 27.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 31 | 84 | $25,800 | $4,356 | 16.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 12 | 37 | $22,000 | $4,106 | 18.7% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 16 | 52 | $27,700 | $3,996 | 14.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 76 | $21,250 | $3,788 | 17.8% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 28 | 101 | $25,250 | $3,353 | 13.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 51 | 108 | $4,320 | $1,135 | 26.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 17 | $3,400 | $369.20 | 10.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 17 | 27 | $1,080 | $158.80 | 14.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 77 | $3,080 | $62.90 | 2.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 53 | 143 | $2,145 | $60.25 | 2.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 420 | 1,805 | $714,250 | $157,066 | 22.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 23 | 13,000 | $324,000 | $63,668 | 19.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 109 | 165 | $82,250 | $20,844 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 52 | 52 | $28,600 | $7,947 | 27.8% |
| 97124 | Therapy procedure using massage, each 15 minutes | Office | 2022 | 18 | 394 | $15,760 | $6,929 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 117 | $32,600 | $6,199 | 19.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 17 | 45 | $27,000 | $5,254 | 19.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 22 | 79 | $25,500 | $4,244 | 16.6% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 17 | 47 | $25,700 | $3,858 | 15.0% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 32 | 97 | $24,250 | $3,461 | 14.3% |
About Dr. Robert Hansen, MD
Dr. Robert Hansen, MD is a Pain Medicine healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619969227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hansen, MD has received a total of $12,422 in payments from pharmaceutical and medical device companies, with $367.04 received in 2024. These payments were reported across 758 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($11,716).
As a Medicare-enrolled provider, Hansen has provided services to 3,796 Medicare beneficiaries, totaling 55,240 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Norfolk, VA
- Active Since 08/19/2005
- Last Updated 04/06/2016
- Taxonomy Code 2084P2900X
- Entity Type Individual
- NPI Number 1619969227
Products in Payments
- UBRELVY (Drug) $1,604
- XTAMPZA (Drug) $859.95
- Aimovig (Biological) $711.14
- RELISTOR (Drug) $700.45
- VYEPTI (Biological) $660.21
- AIMOVIG (Biological) $650.21
- NURTEC ODT (Drug) $621.35
- BOTOX (Biological) $550.08
- Horizant (Drug) $307.77
- QULIPTA (Drug) $263.87
- Zembrace (Drug) $257.29
- Movantik (Drug) $246.23
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $222.51
- Morphabond ER (Drug) $211.33
- Trintellix (Drug) $181.01
- Nucynta (Drug) $177.20
- Amitiza (Drug) $168.19
- AJOVY (Biological) $166.70
- TROKENDI XR (Drug) $160.59
- SPRIX (Drug) $141.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Norfolk
Dr. Antonio Quidgley-Nevares, Md, MD
Pain Medicine — Payments: $27,515
Pain Medicine $27,515
Dr. Mihir Patel, M.d, M.D
Pain Medicine — Payments: $11,907
Pain Medicine $11,907
Ihsan Balkaya, Md, MD
Pain Medicine — Payments: $8,577
Pain Medicine $8,577
James Bertus, Md, MD
Pain Medicine — Payments: $6,854
Pain Medicine $6,854
Dr. Edward Walko, Do, DO
Pain Medicine — Payments: $1,616
Pain Medicine $1,616
Joann Dervay, Md, MD
Pain Medicine — Payments: $842.54
Pain Medicine $842.54